While this gene has not previously been associated with head and neck cancer risk, germline variation in ARID5B has been implicated in acute lymphoblastic leukemia (ALL) [47], as well as treatment resistance and higher rates of relapse [48]. Here, ARID5B is linked to head and neck cancer.